Envestnet Asset Management’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Envestnet Asset Management’s Portfolio AUGX Stock Details AUGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-11,158	Closed	-$57.5K	–	4198
2023 Q3	$57.5K	Sell	11,158 -589	-5%	-$2.76K	﹤0.01%	3928
2023 Q2	$56.5K	Buy	11,747 +420	+4%	+$1.45K	﹤0.01%	3864
2023 Q1	$19.7K	Sell	11,327 -220	-2%	-$359	﹤0.01%	3926
2022 Q4	$18K	Sell	11,547 -1,031	-8%	-$1.31K	﹤0.01%	3929
2022 Q3	$18K	Buy	12,578 +2,247	+22%	+$3.85K	﹤0.01%	3872
2022 Q2	$19K	Buy	+10,331	New	+$23.9K	﹤0.01%	3883
2022 Q1	–	Sell	-10,483	Closed	-$33K	–	4087
2021 Q4	$33K	Buy	+10,483	New	+$38K	﹤0.01%	3833

Other funds holding AUGX

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Samjo Management New York $231M AUM 13.04% 1-Year Est. Return

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

GIPM

G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return

AAP

Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

AFG

American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return

Envestnet Asset Management's AUGX Position: Q4 2023 in Review

Envestnet Asset Management sold out of Augmedix, Inc. Common Stock (AUGX) in Q4 2023, closing a stake of 11,158 shares — an estimated $57.5K sold.

Envestnet Asset Management first reported a position in AUGX in Q4 2021 and held it in 7 quarters. The position peaked at $57.5K in Q3 2023. 85 funds tracked by Wall St. Rank hold AUGX as of Q4 2023.

Envestnet Asset Management reported no remaining Augmedix, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Envestnet Asset Management sold 11,158 Augmedix, Inc. Common Stock shares in Q4 2023, an estimated $57.5K.
Envestnet Asset Management first reported a position in Augmedix, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
Envestnet Asset Management's Augmedix, Inc. Common Stock position peaked at $57.5K in Q3 2023.
85 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q4 2023.

Based on Envestnet Asset Management's 13F filing for Q4 2023, filed 13 Feb 2024.